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Abstract
Liver X receptors (LXRs) are ligand-activated transcription factors of the nuclear receptor superfamily. They play important
roles in controlling cholesterol homeostasis and as regulators of inflammatory gene expression and innate immunity, by
blunting the induction of classical pro-inflammatory genes. However, opposite data have also been reported on the
consequences of LXR activation by oxysterols, resulting in the specific production of potent pro-inflammatory cytokines and
reactive oxygen species (ROS). The effect of the inflammatory state on the expression of LXRs has not been studied in
human cells, and constitutes the main aim of the present work. Our data show that when human neutrophils are triggered
with synthetic ligands, the synthesis of LXRa mRNA became activated together with transcription of the LXR target genes
ABCA1, ABCG1 and SREBP1c. An inflammatory mediator, 15-deoxy-D12,14-prostaglandin J2 (15dPGJ2), hindered T0901317-
promoted induction of LXRa mRNA expression together with transcription of its target genes in both neutrophils and
human macrophages. This down-regulatory effect was dependent on the release of reactive oxygen species elicited by
15dPGJ2, since it was enhanced by pro-oxidant treatment and reversed by antioxidants, and was also mediated by ERK1/2
activation. Present data also support that the 15dPGJ2-induced serine phosphorylation of the LXRa molecule is mediated by
ERK1/2. These results allow to postulate that down-regulation of LXR cellular levels by pro-inflammatory stimuli might be
involved in the development of different vascular diseases, such as atherosclerosis.
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Introduction
Liver X receptors (LXRs) are oxysterol-activated nuclear
receptors active in different human and rodent cells, such as
macrophages, adipocytes, hepatocytes, skin fibroblasts and myo-
tubes, which regulate the expression of genes linked to cholesterol
metabolism in a tissue-specific manner [1,2]. This includes the
modulation in peripheral blood cells, such as macrophages, of the
transcription of a panel of genes encoding proteins involved in
reverse cholesterol transport, such as the ATP-binding cassette
(ABC) transporters ABCA1 and ABCG1, the lipoproteins ApoE
and ApoC, and the lipoprotein-remodelling enzyme PLTP [3,4].
Systemic activation of LXR thus initiates a series of tissue-specific
transcriptional programs aimed at regulating whole-body choles-
terol content. For instance, in the intestine LXR controls the
reabsorption of cholesterol via activation of ABCG5 and ABCG8
gene expression [5]. Pharmacological activation of LXRs in vivo
thereby results in increased high-density lipoprotein (HDL) levels,
net whole-body cholesterol loss, and reduced atherosclerosis [6,7].
In addition to their key role in cholesterol homeostasis, LXRs
have emerged as important regulators of genes involved in the
inflammatory response and innate immunity. Ligand-activated
LXR thus blunts the induction of classical pro-inflammatory
genes, such as those encoding inducible nitric oxide synthase
(NOS2), cyclooxygenase-2 (COX-2), matrix metalloproteinase-9
(MMP-9) and various chemokines in response to stimulation by
bacterial lipopolysaccharide (LPS), tumor necrosis factor-a (TNFa)
and interleukin-1b (IL-1b), in different mouse cell lines [8,9].
Other studies have also shown that activation of Toll-like receptors
(TLR) 3 and 4 expression by bacterial and viral components
results in inhibition of LXR signalling via interferon regulatory
factor-3 (IRF-3), a transcription factor, suggesting that LXR
functions to modulate crosstalk between inflammatory and
metabolic pathways [10,11] and that the innate immune response
is under the control of the LXR pathway [12,13]. Moreover, LXR
ligands have proven effective in the amelioration of inflammation
in a number of in vivo assays, including animal models of contact
dermatitis and atherosclerosis [9,14,15]. In addition, activation of
LXR attenuates the LPS-induced release of TNFa and prosta-
glandin E2 (PGE2) in rat Kupffer cells [16]. However, opposite
data have also been reported on the consequences of LXR
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activation by oxysterols. In this light, the treatment of human
peripheral blood monocytes or the differentiated macrophage cell
line THP-1 with an LXR ligand, 22(R)-hydroxycholesterol, results
in the specific induction of the potent pro-inflammatory cytokine
TNFa [17]. Also, LXR activation increased the generation of
reactive oxygen species (ROS) by enhancing the expression of
NADPH oxidase subunits in primary human macrophages [18].
In the endoplasmic reticulum of human aortic smooth muscle cells
the NAD(P)H oxidase subunit Nox-4 mediates 7-ketocholesterol-
induced stress [19]. Also in this context, in U937 human
promonocytic leukemia cells oxysterols favour the establishment
of a pro-oxidant state, and a significant O2.
2 overproduction can
be measured in the presence of LXR ligands, such as 7b-
hydroxycholesterol or 7-ketocholesterol [20].
15-Deoxy-D12,14-prostaglandin J2 (15dPGJ2) is an immunoreg-
ulatory lipid metabolite derived from prostaglandin D2 (PGD2)
dehydration in vivo which is abundantly produced by mast cells,
dendritic cells, and alveolar macrophages [21]. As a ligand for the
peroxisome proliferator-activated receptor-c (PPARc), 15dPGJ2
exerts anti-inflammatory effects that modulate vascular inflamma-
tion and atherosclerosis processes [22,23]. However, this property
of 15dPGJ2 remains a controversial matter, and caution must be
taken in assigning this molecule a solely anti-inflammatory role,
given that experimental evidence is also available that 15dPGJ2
can induce the synthesis of the type II-secreted pro-inflammatory
mediators phospholipase A [24] and COX-2 in vascular smooth
muscle [25] and mammary epithelial cells [26]. Moreover, it has
been shown that in stimulated human T lymphocytes 15dPGJ2
promotes a significant increase in interleukin-8 (IL-8) production
through the activation of MAP kinase- and NF-kB-dependent
signalling pathways [27], and that 15dPGJ2 also induces the
expression of IL-8 in human endothelial cells [28]. Furthermore, it
has been shown that this prostaglandin, in contrast to reports in
macrophages and other cell types, acts as a potent activator of
eosinophils by inducing Ca2+ mobilization, actin polymerization
and CD11b expression [29]. In the same line, data from the
present study and a previous report from our laboratory indicate
that 15dPGJ2 exerts a pro-inflammatory action in human
neutrophils, where it elicits the production of high levels of ROS
and induction of heme oxygenase 1 (HO-1) expression [30]. These
facts are in keeping with previous observations in human
neuroblastoma cells [31]. Furthermore, similar data have been
reported by our group in human lymphocytes [32] which are also
in line with recent observations that in human neutrophils and
leukemic Jurkat cells ROS production becomes enhanced in
response to 15dPGJ2 treatment [33].
Although conflicting data are available on the consequences of
LXR activation by oxysterols on the cellular inflammatory state,
the opposite mechanism, that is, the potential effect of oxidative
stress on LXR gene transcription, has not been analyzed in human
circulating neutrophils and constitutes the aim of the present
study. In this context, the pivotal role played by neutrophils as a
source of ROS and mediators promoting oxidative stress and
inflammation, and thereby contributing to the development of
atherosclerosis, has been recently unveiled [34]. Also, classical
observations had shown that neutrophils, although considered as
cells with little protein synthesis capability, are able to synthesize de
novo a series of cytokines, such as IL-1, IL-8 and interferon-a
(IFNa), which are released at sites of inflammation and likely exert
a crucial role in host defence mechanisms and against tissue
damage [35]. These cells, given their high capacity to synthesize
O2.
2, offer a natural approach to analyze the potential effect of
ROS on LXR transcription in human cells, by using 15dPGJ2 as a
pro-inflammatory molecule. We here report for the first time that
human neutrophils when triggered with LXR synthetic ligands
display a notable capacity to activate LXRa gene expression, in
agreement with other cell types, together with the transcription
levels of its target genes ABCA1, ABCG1 and SREBP1c. We
describe as well that the presence of 15dPGJ2 significantly
inhibited the transcription of LXRa and ABC genes elicited by
the synthetic LXR ligand, T0901317, and provide data on the
intracellular signalling mechanisms involved in regulation of
LXRa expression and activity, including oxidative stress and
LXRa phosphorylation. Our results thus allow to extend the
sphere of influence of LXR to human circulating neutrophils.
Methods
Ethics Statement
Peripheral venous blood was drawn from healthy volunteers
following standardized protocols approved by the Research Ethics
Committee of the Hospital Virgen Macarena, Universidad de
Sevilla. The present study meets the requirements for experimen-
tation on human beings, specifically referred to the anonymous
blood samples collection from healthy volunteers, whose consent
was verbal, and additionally complies with the overall Spanish and
European legislation in force, according to the corresponding
ethical report emitted by the Universidad de Sevilla. The
University Ethics Committee approved the use of a verbal consent
protocol with the aim of easing the procedure of sample obtaining
and management, as soon as its providers were kept anonymous at
all times. Blood withdrawing followed a routinary hospital
protocol, and at the moment a simple verbal consent was
requested to patients in our hospital. The blood obtained was
not solely used for research purposes. Measures taken to document
the process included that data handling was strictly kept
anonymous and that our group did not have access to patients
data unrelated to our study. The investigation was designed and
conducted according to the ethical principles for medical research
stated in the Declaration of Helsinki.
Chemicals and Reagents
Phorbol 12-myristate 13-acetate (PMA), phenylarsine oxide,
reduced glutathione (GSH), diethylester maleic acid (DEM),
2,2,6,6-tetramethyl-piperidine-1-oxyl (TEMPO), formyl-Met-
Leu-Phe (fMLP), diisopropyl fluorophosphate (DFP), IL-1b, IL-
8, TNFa, SP600125, and the vitamin E (Vit E) analog 6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid were purchased
from Sigma-Aldrich (Madrid, Spain). SB203580 and PD098059
were products of Calbiochem (San Diego, CA), and RPMI 1640
was obtained from Biomedia (Boussens, France) Fetal calf serum
was obtained from BioWhittaker (Basel, Switzerland). Polyvinyli-
dene difluoride (PVDF) membranes were from Pall (Madrid,
Spain), and Dextran T-500 and lymphocyte separation medium
(Ficoll-Paque) were obtained from GE Healthcare (Barcelona,
Spain). T0901317 and prostaglandins PGA1, PGA2, PGD2 and
PGE2 were products of Cayman Chemical (Ann Arbor, MI).
15dPGJ2 was obtained from Biomol (Plymouth Meeting, PA).
Rabbit polyclonal antibodies against phosphorylated (Thr202/
Tyr204) extracellular signal-regulated kinases 1 and 2 (ERK1/2)
and total (unphosphorylated plus phosphorylated) ERK1/2 were
obtained from New England Biolabs (Beverly, MA). Mouse
monoclonal anti-human LXRa was obtained from Perseus
Proteomics (Tokyo, Japan). Rabbit polyclonal anti-phosphoserine
and mouse monoclonal anti-GAPDH were purchased from
Chemicon International (Madrid, Spain). Horseradish peroxidase
(HRP)-conjugated goat anti-rabbit and anti-mouse IgGs were
from Promega (Madison, WI).
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Isolation and Culture of Human Neutrophils
Human peripheral blood neutrophils were isolated as indicated
[36], from fresh heparinized blood of healthy human donors after
informed consent, and further purified by Dextran T-500
sedimentation, followed by Ficoll-Paque gradient centrifugation
and hypotonic lysis of residual erythrocytes. Neutrophils were
washed twice in Hank’s balanced salt solution and then suspended
at a density of 107 cells/ml in Krebs Ringer Hepes buffer or
RPMI 1640 medium supplemented with 10% fetal calf serum plus
gentamicin, penicillin and streptomycin at 50 mg/ml each. Before
all stimulations, neutrophil suspensions were preincubated at room
temperature with 1 mM DFP (to minimize proteolysis) for 5 min
[37].
Isolation and Culture of Human Macrophages
Human monocyte-derived macrophages were obtained from
buffy coat preparations by Ficoll density gradient centrifugation,
followed by adhesion-mediated purification on tissue culture or
gelatin-coated plastic. The monocytes differentiate into macro-
phages in vitro by culturing in medium containing autologous
human fibrin-depleted plasma [38].
RT-PCR Analyses of mRNA Levels
For RT-PCR analysis, 2 mg of total RNAwas reverse-transcribed
into cDNA as described [32]. Real time PCR was carried out in an
ABI Prism 7300 Sequence Detection System (Applied Biosystems,
Foster City, CA) using the specific thermocycler conditions
recommended by themanufacturer. PCR reactions were performed
in triplicate and contained 2 ml of cDNA and SYBR Green PCR
Master Mix (Applied Biosystems) in a total volume of 25 ml, and
using the following primers: hLXRa: forward, 59-AAGCCCTG-
CATGCCTACGT-39, reverse, 59-TGCAGACGCAGTG-
CAAACA-39; hLXRb: forward, 59-TCGTGGACTTCGCTAAG-
CAA-39, reverse, 59-GCAGCATGATCTCGATAGTGGA-39;
hABCA1: forward, 59-CCCTGTGGAATGTACCTATGTG-39,
reverse, 59-GAGGTGTCCCAAAGATGCAA-39; hABCG1: for-
ward, 59-CAGTCGCTCCTTAGCACCA-39, reverse, 59-
TCCATGCTCGGACTCTCTG-39; hSREBP1c: forward, 59-
TCAGCGAGGCGGCTTTGGAGCAG-39, reverse, 59-
CATGTCTTCGATGTCGGTCAG-39; and b-actin: forward,
59-CCAGCTCACCATGGATGATG-39, reverse, 59-ATGCCG-
GAGCCGTTGTC-39. Relative levels of transcripts above were
quantified by the comparative threshold cycle (Ct) method as
described in the ABI Prism 7300 User Bulletin 2 [30], and
normalized to b-actin mRNA levels.
Western Blotting Analysis of LXRa, Phosphorylated ERK1/
2 and Phosphoserine Levels
Cells were rinsed once with ice-cold PBS, resuspended in a lysis
solution containing 50 mM Tris-HCl (pH 7.4), 10 mM EDTA,
50 mM NaF, 10% glycerol, 1% Triton X-100, 10 mg/ml
leupeptin, 10 mg/ml aprotinin and 1 mM phenylmethylsulfonyl
fluoride (PMSF), and kept on ice for 30 min. Then the cells were
disrupted by sonication on ice and, after centrifugation at
12,0006g for 5 min at 4uC, protein concentration in the
supernatant was determined by the Bradford method [39], using
bovine serum albumin (BSA) as a standard. Proteins [40] were
boiled in Laemmli loading buffer, resolved by SDS-PAGE (10%
polyacrylamide) and transferred to PVDF membranes as previ-
ously described [41] The blots were probed without need of prior
blocking [42] with mouse monoclonal anti-LXRa or with rabbit
polyclonal anti-phospho ERK1/2 or anti-phosphoserine antibod-
ies at a 1:1,000 dilution in PBS plus 0.5% BSA and 0.02% Tween-
20. Thereafter, HRP-conjugated antibodies to mouse or rabbit
IgG were used at a 1:5,000 dilution in PBS plus 0.5% casein
followed by enhanced chemiluminescence [36]. To verify even
protein loading, the blots were subsequently stripped and reprobed
with mouse monoclonal antibodies against GAPDH, or rabbit
polyclonal antibodies against total ERK1/2 at a 1:1,000 dilution.
Band intensities were measured by scanning densitometry analysis
using the Scion Image software (Frederick, MD).
Immunoprecipitation Analysis of Serine-phosphorylated
Proteins
Stimulated cells were pelleted and lysed in 75 ml of ice-cold lysis
buffer B, containing 50 mM Tris-HCl (pH 7.4), 1% Triton X-100,
300 mM NaCl, 100 mM phenylarsine oxide, 10 mg/ml leupeptin,
10 mg/ml aprotinin, 1 mM PMSF, 1 mM Na3VO4 and 5 mM
EDTA. The lysates were centrifuged at 12,0006g for 5 min. For
immunoprecipitation, incubation with 0.5 mg of anti-LXRa
specific antibodies was carried out in a volume of 70 ml with
rotation for 2 h at 4uC, followed by addition of 40 ml of a 50%
slurry of protein A-Sepharose beads in buffer B and further
incubation for 2 h at 4uC. The immune complexes were washed
five times with ice-cold lysis buffer B, and the proteins were
extracted by boiling the pellet in Laemmli sample buffer. After
resolution by SDS-PAGE (10% polyacrylamide), the proteins were
electrotransferred to PVDF membranes as previously described
[41], and subjected to immunoblotting analysis with antibodies to
phosphoserine or LXRa as indicated above.
ELISA Quantitation of IL-8 Release
Cell culture supernatants were collected after treatments, and
the levels of secreted IL-8 were quantified using the Human IL-8
ELISA Kit (Raybiotech, Norcross, GA). Plates were read on a
Wallac 1420 Victor2 spectrofluorometer (Perkin Elmer, Madrid,
Spain).
Measurement of ROS using Hydroethidine
Neutrophils were treated as described above in the presence of
2 mM hydroethidine. This reagent is intracellularly oxidized by
oxygen radicals to yield ethidium bromide, which tightly binds to
DNA and emits a strong red fluorescence [43] whose intensity was
measured using excitation/emission wavelengths of 550 nm/
615 nm in the Wallac 1420 Victor2 apparatus (Perkin–Elmer).
Chemotaxis Assay
Migration of neutrophils was evaluated in Transwell migration
chambers (6.5 mm diameter, 5 mm pore size; Costar plates type
3421). Chemoattractants were deposited in the lower compart-
ment in a final volume of 0.6 ml of RPMI 1640, and the plates
were prewarmed at 37uC. Then 0.1 ml of medium containing 106
neutrophils was deposited on each detachable insert, which was
placed over the chemoattractant solution. Loaded chambers were
incubated for 2 h at 37uC in a humidified atmosphere of 5% CO2
in air. In separate wells, neutrophils were added to the lower
compartment and used as controls representing 100% migration.
At the end of the incubation period, the cells that had migrated
into the bottom chambers were collected and centrifuged. After
staining with FITC-conjugated monoclonal antibodies to CD16
(Immunotech, Marseille, France), the cells were fixed with 1%
paraformaldehyde and finally counted on a flow cytometer. The
results are presented as the mean 6 SEM of three separate
experiments, and are expressed as the percentage of total
neutrophils initially added to each chamber.
LXRa Is Modulated by Oxidative Stress
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Cholesterol Efflux
Cholesterol efflux assays were performed as described [44], with
modifications. Cells were washed and incubated for 5 h in RPMI
1640 supplemented with 0.2% BSA with [3H]cholesterol
(2.0 mCi/ml). To equilibrate cholesterol pools, cells were washed
twice with PBS and incubated for 15 hr in RPMI containing 0.2%
BSA plus the indicated ligands (1 mM T0901317 or 10 mM
15dPGJ2) plus or apoAI (15 mg/ml), but lacking radiolabeled
cholesterol. An aliquot of the medium was removed and
centrifuged at 14,0006g for 2 min, and the radioactivity was
determined by liquid scintillation counting. Total cell-associated
radioactivity was determined by dissolving the cells in isopropanol.
Each assay was performed in triplicate.
Detection of Cellular Apoptosis
Apoptosis, measured as DNA fragmentation, was tested using
the Cell Death Detection ELISAplus kit from Roche Applied
Science (Barcelona, Spain), according to the manufacturer’s
instructions. No evidence of apoptotic death was found in our
cells, even after 20 h of incubation in our experimental conditions.
Neutrophils treated with 100 nM staurosporine were used as
positive control.
Statistical Analyses
mRNA levels quantitated by real time PCR are expressed as
fold induction relative to untreated cells (mean 6 SEM from a
minimum of 3 independent experiments performed with similar
results). Protein levels quantitated from Western blots are
expressed in arbitrary units. The results were statistically
analyzed using the Statgraphics Plus 5.0 software (Manugistic
Inc., Rockville, MD) by means of ANOVA and the Student’s
paired t-test.
Results
15dPGJ2 Inhibits the Expression of LXRa and its
Regulated Genes in Human Neutrophils
In preliminary experiments, we attempted to transfect human
circulating neutrophils with plasmids containing cloned LXR
genes or a short interfering RNA (siRNA) specific for the human
LXRa. Yet, these experiments were unsuccessful, likely due to the
intrisic difficulty posed by these cells to become transfected with
DNA. Initial experiments were designed to analyze whether each
of the two LXR isoforms, a and b, was present at basal levels in
human neutrophils. A relative quantification of LXRa and LXRb
mRNAs in untreated human neutrophils and macrophages by
means of real time RT-PCR revealed that these two cell types
expressed comparable basal levels of both LXR genes (Figure 1A).
However, we found that only the LXRa mRNA was induced in
human neutrophils by a synthetic ligand, T0901317, whereas the
LXRb mRNA was constitutively expressed by these cells and its
levels remained unchanged (Figure 1B). As shown, the LXRa
mRNA levels became up-regulated between 3 and 6 times after
treatment for 18 h with T0901317, as measured in human
neutrophils by real-time RT-PCR (Figure 1B). Next, experiments
were designed to analyze the potential role on this process of
15dPGJ2, a ligand of PPARc with capacity to modify the
intracellular redox status, although with conflicting results
reported on whether it enhances or ameliorates the inflammatory
response. Interestingly, although 15dPGJ2 by itself did not exert
any positive or negative effect on LXRa mRNA expression (data
not shown), it was able to drastically inhibit the stimulation of this
process exerted by T0901317 in human neutrophils (Figure 1B),
Indeed, 15dPGJ2 effectively counteracted T0901317-activated
LXRa expression, although only at 10 mM its inhibitory effect
was consistently observed and statistically significant, by ca. 75%
(Figure 1B). Furthermore, the inhibition of LXRa mRNA
expression correlated with decreased levels of LXRa protein in
15dPGJ2-treated neutrophils (Figure 1C). A decrease of basal
LXRa protein was also seem in the presence of 15dPGJ2 alone
(Figure 1C), although this small effect was not consistently
observed.
We then set to analyze the effect of 15dPGJ2 on the intracellular
redox status in human neutrophils. To this end, we measured the
short-term ROS production by neutrophils incubated with
15dPGJ2. It was found that 15dPGJ2 was able by itself to induce
within minutes the production of ROS by these cells (Figure 1D).
Moreover, the LXR synthetic ligand, T0901317, did not induce
by itself ROS production (data not shown), although it reduced
ROS generation elicited by 15dPGJ2 (Figure 1D). These facts
suggested that T0901317 did modify the intracellular redox status
in human neutrophils. It was noteworthy that under pro-oxidant
conditions, i.e. cells treated with diethylester maleic acid (DEM),
an oxidant that depletes glutathione in the cell, the effect of
T0901317 on ROS generation was reversed (Figure 1D). These
data demonstrated that oxidative stress could change an LXR-
mediated cell function in human neutrophils. Neither T0901317
nor DEM affected significantly ROS production by themselves
(data not shown). In order to further assess the pro-inflammatory
properties of 15dPGJ2 and anti-inflammatory effects of LXR
activation, we studied its effects on the release of IL-8, the main
interleukin produced by neutrophils under pro-oxidant conditions.
Figure 1E shows that 15dPGJ2 strongly induced a significant IL-8
release to the medium by human neutrophils, and that this effect
was hindered by subsequent T0901317 treatment. Thus, for both
parameters measured, i.e. ROS and IL-8 levels, 15dPGJ2 clearly
exhibited pro-inflammatory properties in human neutrophils,
which were significantly altered by T0901317 treatment. It should
be noted that the effect of T0901317 on ROS and IL-8 levels was
only observed after a previous treatment for at least 4 h with the
ligand. Furthermore, T0901317 treatment for this period also
hindered neutrophil migration activity induced by 15dPGJ2 or by
the chemoattractant formyl-Met-Leu-Phe (fMLP) (Figure 1F),
these data demonstrated that LXRa plays a role in regulation of
inflammation. Also, we studied its role in cholesterol homeostasis.
With this purpose, we analysed the efflux of cholesterol in human
neutrophils in the presence and absence of T0901317 and/or
15dPGJ2. However, this ligand was unable to alter cholesterol
levels (data not shown).
To investigate whether the inhibitory effect of 15dPGJ2 was
specific for the LXRa in human neutrophils, we examined its
biological activity by measuring the mRNA levels of a series of
genes activated by this transcription factor, such as those
encoding the cholesterol efflux transporters ABCA1 and
ABCG1. It was found that the T0901317-activated transcription
of these two genes was partially prevented by 15dPGJ2
pretreatment (Figure 2, A and B), with an observed inhibition
of ca. 40% for each ABCA1 and ABCG1 transcript levels with
respect to those measured with T0901317 alone. SREBP1c was
another LXR-dependent gene whose transcription, as shown in
Figure 2C, was as well hindered by 15dPGJ2 in neutrophils
stimulated with T0901317, although, in this case such negative
effect was not statistically significant. From these experiments it
was concluded that transcription of the LXRa and its target
genes induced by LXR ligands was inhibited by the simulta-
neous presence of 15dPGJ2 in human neutrophils. Since the
majority of previous studies on LXR gene transcription had
been performed on macrophages, we set to verify whether the
LXRa Is Modulated by Oxidative Stress
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inhibitory effect of 15dPGJ2 also took place in this cell type. As
illustrated in Figure 2D, 15dPGJ2 inhibited as well LXRa,
ABCA1, ABCG1 and SREBP1c mRNA transcription in
cultured human macrophages treated with T0901317, although,
as it was the case for neutrophils, the 15dPGJ2 inhibitory effect
on SREBP1c was not statistically significant.
Other Pro-inflammatory Molecules also Inhibit LXRa
mRNA Expression in Human Neutrophils
In order to investigate whether the inhibitory effect of 15dPGJ2
was attributable to its pro-inflammatory properties, we studied the
effect of well known pro-inflammatory cytokines, namely IL-8, IL-
1b and TNFa, on LXRamRNA levels as well as on the expression
of LXRa target genes, ABCA1, ABCG1 and SREBP1c. Figure 3A
shows that these cytokines not only inhibited the ligand-induced
Figure 1. 15dPGJ2 prevents ligand-induced LXRamRNA expression in a dose-dependent manner. Neutrophils or macrophages were left
untreated (A), or else neutrophils were preincubated at 37uC for 1 h with or without 15dPGJ2 at the indicated doses (B) or at a 10 mM concentration
(C), and then they were treated or not with T0901317 for 18 h (B and C). Then LXRa and LXRbmRNA levels were measured by real time RT-PCR (A and
B), or LXRa protein levels were analyzed by Western blotting (C). Statistical data from real time RT-PCR experiments were normalized to LXRa or LXRb
levels found in human macrophages (A) and corrected for differences in b-actin mRNA levels (as endogenous gene) and expressed as fold induction
(A and B). GAPDH bands in Western blots are shown for the sake of protein loading controls (C). In a different set of experiments, neutrophils were
pretreated or not with 10 mM DEM for 30 min (D and E) and, after preincubation in the absence or presence of 1 mM T0901317 for 4 h (D and E),
10 mM 15dPGJ2 was added and ROS levels were monitored by luminescence measurement for the next 6 h (D), or released IL-8 levels were
quantitated by ELISA after an incubation period of 4 h (E). Neutrophil migration was quantitated in cells preincubated with or without 1 mM
T0901317 for 4 h and then transferred to Transwell chambers and treated with 10 mM 15dPGJ2 or 0.1 mM fMLP for 1 h. Results are expressed as the
percentage of cells that migrated from the upper to the lower compartment (F). Each panel is representative of a set of three experiments yielding
similar results. Values are plotted as the mean 6 SEM (n= 3) (A, B, D, E and F). * P,0.01 for T0901317-stimulated, 15dPGJ2 (B, F) or fMLP (F)-treated
versus -untreated. e P,0.01 for 15dPGJ2-treated versus untreated (E). ** P,0.01 for 15dPGJ2 and T0901317-stimulated, DEM-treated versus -
untreated (E).
doi:10.1371/journal.pone.0042195.g001
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LXRa mRNA expression, but also that of LXRa target genes,
ABCA1, ABCG1 and SREBP1c. Yet, the negative effect of IL-1b
on the four genes, although observable, was not statistically
significant, as it was the case for the TNFa effect on ABCA1
induction (Figure 3A). Interestingly, IL-8 inhibited LXRa mRNA
expression at a dose similar to IL-8 levels released upon 15dPGJ2
treatment by human neutrophils.
15dPGJ2 is a known PPARc natural ligand. Some authors have
described that LXR and PPARc ligands act in a cooperative
manner to induce LXRa expression in human macrophages [1].
Thus, we decided to investigate whether the inhibitory effect of
15dPGJ2 was dependent on PPARc activation. To address this
question, we treated neutrophils with three synthetic PPARc
agonists, troglitazone, ciglitazone and rosiglitazone, at a 1 mM
concentration. As shown in Fig. 3B, these compounds did not
significantly affect either the basal levels of LXRa mRNA
expression or its T0901317-induced transcription in human
neutrophils. Similar negative results were obtained for ABCA1
expression (Fig. 3B). These observations were suggestive that
15dPGJ2 inhibits LXRa expression in a PPARc-independent
manner.
Given that the effects of cyclopentenone prostaglandins, like
15dPGJ2 and A-series prostaglandins, are usually mediated by the
reactive a,b-unsaturated carbonyl group in their cyclopentenone
ring [45], subsequent experiments were addressed to study the
effect on LXRa expression of prostaglandins A, which do not bind
to any member of the PPAR family of nuclear receptors. Figure 3C
illustrates that T0901317-promoted LXRa mRNA synthesis was
strongly inhibited by both PGA1 and PGA2 in human neutrophils.
Moreover, PGD2, the precursor of 15dPGJ2 [31], also prevented
LXRa gene expression, whereas PGE2 had no significant effect on
its induction by T0901317. Similar inhibitory effects were detected
for these prostaglandins on the three LXRa target genes analyzed
(Figure 3C), although their negative effect on SREBP1c expression
was (as in Figure 2D) not statistically significant.
Inhibition of LXRa Transcription by 15dPGJ2 is Exerted
through ROS
Our group has shown that some effects of 15dPGJ2 are exerted
through its intrinsic ability to elicit ROS production by human
lymphocytes and neutrophils [30,31]. We thus tested whether the
negative effect of 15dPGJ2 on LXRa mRNA expression was
affected by oxidative stress. With this purpose, neutrophils were
preincubated with either the pro-oxidant agent, DEM, or the
reducing molecules 2,2,6,6-tetramethyl-piperidine-1-oxyl (TEM-
PO) (a ROS scavenger), 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid (a soluble Vit E analog), or GSH, prior to addition
of 15dPGJ2 to the medium, and then LXRa mRNA synthesis was
activated with T0901317. Figure 4A illustrates that DEM
significantly inhibited by itself T0901317-dependent mRNA
expression of the LXRa and its target genes (i.e. ABCA1, ABCG1
and SREBP1c) (P,0.01), and that it was also able to enhance the
negative effect of 15dPGJ2 on the mRNA levels of LXRa target
genes, but not on LXRa expression, possibly due to the strong
inhibition exerted by 15dPGJ2 by itself (Figure 4A). Even, DEM
alone was able to decrease LXRa expression below basal levels,
Figure 2. 15dPGJ2 prevents T0901317-induced ABCA1, ABCG1 and SREBP1c mRNA expression in human neutrophils and
macrophages. Neutrophils (A-C) or macrophages (D) were preincubated at 37uC with or without 10 mM 15dPGJ2 for 1 h, and thereafter they were
stimulated or not with 1 mM T0901317 for 18 h. The levels of mRNA from the indicated genes were analyzed by real time RT-PCR. Statistical data
(mean 6 SEM, n= 3) were corrected for differences in b-actin mRNA levels and expressed as fold induction. * P,0.01 for T0901317-stimulated,
15dPGJ2-treated versus -untreated.
doi:10.1371/journal.pone.0042195.g002
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although not significantly. In contrast, reducing molecules such as
TEMPO (Figure 4A) and the Vit E analog (Figure 4B) significantly
counteracted the negative effect of 15dPGJ2 on LXRa mRNA
expression with a statistical significant of P,0.01, and GSH totally
abolished such effect with a statistical significant of P,0.01
(Figure 4B). Interestingly, the counterbalancing effect of reducing
molecules was also significant on the other three LXRa target
genes studied, with a statistical significant of P,0.01, except for
TEMPO, which was not able to reverse the negative effect of
15dPGJ2 on the expression of these genes (Figure 4A). In control
experiments, it was found that neither the Vit E analog (Figure 4B)
nor TEMPO or GSH (data not shown) alone had any effect on
T0901317 stimulatory action. These data strongly suggested that
intracellular ROS are involved in the inhibition of LXRa mRNA
synthesis exerted by 15dPGJ2 in human neutrophils treated with
T0901317.
LXRa Expression is ERK1/2-dependent in Human
Neutrophils: Effect of 15dPGJ2
Recently, Tontonoz’s and Garabedian’s groups have established
that the LXRa molecule is phosphorylated at a single site, Ser-
198, in its hinge region [46,47]. This serine residue is a target site
for mitogen-activated protein kinase (MAPK) phosphorylation.
On this basis, we analyzed in subsequent experiments the potential
involvement of MAPK pathways in LXR mRNA expression and
its down-regulation promoted by 15dPGJ2 in human neutrophils.
With this aim, neutrophils were incubated with different kinase
inhibitors, such as SB203580 (a p38 MAPK inhibitor), PD098059
(an inhibitor of MEK1/2, the upstream activator of ERK1/2), and
SP600125 (an inhibitor of c-Jun N-terminal kinases 1 and 2,
JNK1/2), prior to addition of 15dPGJ2 to the medium. As shown
in Figure 5A, neither SB203580 nor SP600125 had any significant
effect on T0901317-promoted LXRa transcription, nor did they
alter the negative effect of 15dPGJ2 on this process. This suggested
that the MAPKs p38 and JNK1/2 are not involved in LXRa
transcription. However, in neutrophils preincubated with
PD098059, the MEK1/2 inhibitor, LXRa target genes mRNA
synthesis induced by T0901317 was dramatically enhanced in a
PD098059 (Figures 5, A and B). Even, this inhibitor was able by
itself to (slightly) induce LXRa target genes mRNA expression
above basal levels (Figure 5B), and to potently abrogate the
15dPGJ2 inhibitory effect on this process (Figures 5, A and B).
These data were indicative that ERK1/2 activation down-
Figure 3. Pro-inflammatory cytokines and prostaglandins, but not PPAR agonist, inhibit induction of mRNA expression of LXRa
target genes in human neutrophils. Neutrophils were preincubated at 37uC for 1 h with or without 330 ng/ml IL-1b, 200 ng/ml TNFa or IL-8 at
the indicated doses (A), 1 mM troglitazone, 1 mM ciglitazone or 1 mM rosiglitazone (B),or else with 10 mM 15dPGJ2, 10 mM PGD2, 10 mM PGE2, 15 mM
PGA1 or 25 mM PGA2 (C). Then, after incubation in the absence or presence of 1 mM T0901317 for 18 h, the levels of LXRa, ABCA1, ABCG1 and
SREBP1c mRNAs were analyzed by real time RT-PCR. Statistical data (mean 6 SEM, n = 3) were corrected for differences in b-actin mRNA levels and
expressed as fold induction. * P,0.01 for treated with pro-inflammatory cytokines (A) or prostaglandins (C) plus T0901317-stimulated versus
untreated, T0901317-stimulated only.
doi:10.1371/journal.pone.0042195.g003
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regulates LXRa target genes mRNA transcription induced by
T0901317, and that the inhibitory effect of 15dPGJ2 could be
mediated by ERK1/2 activation.
15dPGJ2 Elicits Redox-dependent Phosphorylation of
ERK1/2 in Human Neutrophils
To further assess whether 15dPGJ2 was able to activate the
ERK1/2 pathway in human neutrophils, we studied its effect on
the phosphorylation status of this MAPK. With this purpose,
neutrophils were incubated with PMA, a known ERK1/2
activator used as a positive control, and with 15dPGJ2 for different
times (5–60 min). As illustrated in Figure 6A, 15dPGJ2 elicited
ERK1/2 phosphorylation in a time-dependent manner, reaching
its maximal value after 30 min of treatment. Given that exogenous
oxidants are known to promote phosphorylation, and hence
activation, of p38 MAPK and ERK1/2 in human neutrophils
[48,49], we set to analyze whether oxidative stress was implicated
in ERK1/2 phosphorylation induced by 15dPGJ2. Thus, neutro-
phils were treated either with the oxidant reagent DEM, or with
the reducing molecules Vit E (analog) or GSH, prior to addition of
15dPGJ2 to cells. As shown in Figure 6B, DEM preincubation
slightly enhanced ERK1/2 phosphorylation elicited by 15dPGJ2,
mainly of its lower, p42 band. This result was in agreement with
the increased ERK1/2 phosphorylation observed upon glutathi-
one depletion with buthionine sulfoximine in HepG2 hepatocytes
[50]. On the other hand, both the Vit E analog and GSH
separately hindered the positive effect of 15dPGJ2 on ERK1/2
phosphorylation in human neutrophils (Figure 6B). However,
neither Vit E or GSH had any effect by itself on this process (data
not shown). Like 15dPGJ2, other cyclopentenone prostaglandins,
such as PGA1 and PGA2 and the 15dPGJ2 precursor, PGD2,
promoted as well ERK1/2 phosphorylation in human neutrophils,
Figure 4. 15dPGJ2 inhibition of LXR target genes mRNA expression is mediated by oxidative stress in human neutrophils.
Neutrophils were preincubated at 37uC with or without 10 mM DEM, 100 mM TEMPO (A), 100 mM vitamin E analog (Vit E) or 1 mM GSH (B) for 1 h.
Then the cells were treated or not with 10 mM 15dPGJ2 for 1 h, and thereafter stimulated or not with 1 mM T0901317 for 18 h. Finally, the levels of
LXRa target genes mRNAs were analyzed by real time RT-PCR. Statistical data (mean 6 SEM, n = 3) were corrected for differences in b-actin mRNA
levels and expressed as fold induction. * P,0.01 for T0901317–stimulated, 15dPGJ2 (A and B) or DEM (A)-treated versus -untreated.
e P,0.01 for
15dPGJ2 and T0901317-stimulated, TEMPO (A), Vit E or GSH (B)-treated versus -untreated.
doi:10.1371/journal.pone.0042195.g004
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although not at the high level elicited by 15dPGJ2 (Figure 6C).
These results confirmed the possibility that 15dPGJ2 could act
through mechanisms related to the reactive a,b-unsaturated
carbonyl group in its cyclopentenone ring (Figure 6C). The much
lower effect of PGD2 compared to 15dPGJ2 (Figure 6C) could be
attributed to the short preincubation period (30 min) with the
cells, possibly insufficient for its intracellular conversion into
15dPGJ2. In this light, longer preincubations, of up to 20 h,
resulted in a much stronger enhancement of ERK1/2 phosphor-
ylation by exogenously-added PGD2 (Figure 6D). In contrast,
T0901317 was unable to stimulate ERK1/2 phosphorylation by
itself (Figure 6E), but instead inhibited PMA-induced phosphor-
ylation of this MAPK (data not shown).
15dPGJ2 Promotes LXRa Serine Phosphorylation in
Human Neutrophils
The human LXRa is well known to be an autoinducible gene
[1,2]. Also, nuclear receptor activity can be regulated by
phosphorylation [51,52], and previous studies have suggested that
different signalling pathways may contribute to LXRa phosphor-
ylation [53,54]. In this context, Garabedian’s group has provided
clear evidence of regulation of LXRa target gene selectivity
through modulation of LXRa phosphorylation at Ser-198 in
mouse macrophages [47]. Based on these data, we studied LXRa
phosphorylation levels in human neutrophils. To this end, these
cells were incubated with 15dPGJ2 prior to their treatment with
T0901317, the LXRa was immunoprecipitated, and Western
blotting analysis was carried out using anti -phosphorylated-serine
antibodies. Figure 7 illustrates that untreated human neutrophils
exhibited basal levels of LXRa serine phosphorylation, and that
T0901317 incubation enhanced the serine phosphorylation status
of this transcription factor. We also found that 15dPGJ2 further
enhanced LXRa phosphorylation in human neutrophils, although
at undetermined serine residue(s). It is noteworthy that this effect
was counteracted by preincubation with PD098059, a ERK1/2
inhibitor (Figure 7).
Figure 5. 15dPGJ2 inhibition of LXR target genes mRNA expression is mediated by ERK1/2 in human neutrophils. Neutrophils were
pretreated at 37uC with or without 10 mM SB203580 or 1 mM SP600125, or with PD098059 at 40 mM (A) or at the indicated doses (B) for 1 h. Then the
cells were incubated in the absence or presence of 10 mM 15dPGJ2 for 1 h, and further stimulated or not with 1 mM T0901317 for 18 h. Finally, the
levels of LXR target genes mRNA were analyzed by real time RT-PCR. Statistical data (mean 6 SEM, n = 3) were corrected for differences in b-actin
mRNA levels and are expressed as fold induction. * P,0.01 for T0901317-stimulated, 15dPGJ2-treated versus -untreated. ** P,0.01 for T0901317-
stimulated, PD098059-treated versus -untreated. e P,0.01 for 15dPGJ2 plus T0901317-stimulated, PD098059-treated versus -untreated.
doi:10.1371/journal.pone.0042195.g005
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Discussion
The main role traditionally assigned to LXRs is triggering
transcriptional programs that promote reverse cholesterol trans-
port. However, as indicated above, there has been a growing
appreciation in recent years of its complex roles in innate
immunity using established cell lines [8,9]. In the present work
we extend the sphere of influence of LXR to human circulating
neutrophils. Our studies show that when this cell type is triggered
with an LXRa synthetic ligand, it exhibits a notable capacity to
activate the transcription of the LXRa target genes ABCA1,
ABCG1 and SREBP1c. Moreover, this ligand also induced LXRa
expression itself at the mRNA and protein levels. These results
confirm recent observations that identify neutrophils as target cells
for LXR activation in mice [55]. These studies have demonstrated
that the expression of LXRa (but not LXRb) is controlled by an
autoregulatory mechanism. Therefore, LXR activity is modulated
not only by agonist and antagonist agents, but also through
activation of LXR mRNA transcription exerted by LXRa itself
[56]. Although most studies on LXR have been devoted to
macrophages and endothelial cells, human neutrophils may play
an important role in the pathogenesis of atherosclerosis, given their
capacity to respond to exogenous oxysterols and circulating
molecules, especially under pro-inflammatory conditions. The
traditional notion of atherosclerosis as a predominantly lipid-
retentive disease has been recently expanded to a coupling of
Figure 6. 15dPGJ2-promoted ERK1/2 phosphorylation is dependent on oxidative stress in human neutrophils. Neutrophils were
preincubated at 37uC with or without 10 mM DEM, 100 mM Vit E or 1 mM GSH for 1 h (B). Then the cells were treated or not with 10 mM 15dPGJ2 for
the indicated times (A) or for 30 min (B, C and E), and then with 100 nM PMA for 7 min (A and B), or else with 10 mM PGD2, 15 mM PGA1 or 25 mM
PGA2 for 30 min (C), with 10 mM PGD2 for 20 h (D), or with 1 mM T0901317 for 30 min (E). Phosphorylated ERK1/2 (pERK1/2) levels were analyzed on
cell lysates by Western blotting and are given in arbitrary units. Immunoblots of total ERK1/2 (A-D) or GAPDH (E) are also shown for the sake of
loading controls. Each blot is representative of a set of three separate experiments yielding similar results.
doi:10.1371/journal.pone.0042195.g006
Figure 7. 15dPGJ2 promotes LXRa serine phosphorylation in
human neutrophils. Neutrophils were preincubated at 37uC with or
without 30 mM PD098059 for 30 min. Then the cells were treated or not
with 10 mM 15dPGJ2 for 30 min, and thereafter stimulated or not with
1 mM T0901317 for further 30 min. Finally, the cells were lysed, LXRa
was immunoprecipitated and Western blotting analysis of phosphoser-
ine (P-Ser) and LXRa levels was carried out as indicated in Experimental
Procedures. P-Ser levels are given in arbitrary units. The blot is
representative of a set of three experiments yielding similar results.
doi:10.1371/journal.pone.0042195.g007
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inflammatory mechanisms and dyslipidemia [57]. Under this view,
oxidative stress and chronic inflammation are likely involved in,
and contribute to, the development of atherosclerosis [58,59]. In
this context, primed neutrophils constitute a source of superoxide
radicals (O2.
2) and mediators that can promote oxidative stress
and inflammation [34], whose overproduction may represent a
risk factor for cardiovascular diseases [60]. The LXR nuclear
receptor is generally considered as an anti-inflammatory factor,
given that it hinders the expression of classical pro-inflammatory
genes [8], In this line, we show evidence that T0901317 treatment
was able to ameliorate neutrophil migration activity induced by
pro-inflammatory agents (such as 15dPGJ2 and fMLP). Moreover,
T0901317 treatment reverted the pro-inflammatory effect of
15dPGJ2 (i.e. ROS production, IL-8 release), But it is important to
underline that these effects occurred only after long term
treatment with T0901317 (i.e. 4 h). Thus the activation of LXR
may play a role in resolution of inflammation processes.
Although it has been shown that under oxidative stress
conditions the NADPH oxidase system becomes activated in
murine macrophages treated with oxysterols [61], and that in
cultured porcine retinal pigment epithelial cells oxysterols induce a
significant increase of ROS production and IL-8 gene expression
[62], the discrepancy existing on the relationship between
oxysterols and oxidative stress could reflect differences between
animal species or cell lines in their response to these compounds.
However, the opposite situation, that is, the potential effect of
oxidative stress on LXR gene expression, has not been analyzed in
human circulating neutrophils and constitutes one of the aims of
the present study. The main role of neutrophils as a source of ROS
(e.g., superoxide radicals) and pro-inflammatory mediators (e.g.,
15dPGJ2), thereby promoting oxidative stress and contributing to
the development of atherosclerosis, is well known [34]. Therefore,
these cells offer a natural approach to analyze the potential effect
of ROS on LXR transcription in human cells, by using 15dPGJ2
as a pro-inflammatory molecule. As indicated, 15dPGJ2 could be
considered either as a pro- or anti-inflammatory molecule
depending on cells under study, their context and the prostaglan-
din receptor implicated [63]. However, our present data provide
clear evidence that 15dPGJ2 exerts pro-inflammatory effects in
human neutrophils, since it induces ROS production at high levels
by this cell type. This effect was dependent on its cyclopentenone
ring, and in this context it has been reported that some 15dPGJ2
biological actions involve the covalent modification or oxidation of
critical cysteine residues acting as a redox sensor [64]. Addition-
ally, 15dPGJ2 is able to activate cytoprotective mechanisms, such
as the induction of HO-1 expression, in an NF-kB-independent
fashion [30]. Similar results have been described by our group in
human lymphocytes [32], and by other researchers in murine
macrophages [65]. Therefore, accumulating evidence of 15dPGJ2
pro-inflammatory actions [22,23,66,67] taken altogether makes its
anti-inflammatory properties increasingly controversial [24–
27,31].
Two main observations were made in the present study
regarding regulation of LXRa gene expression in human
circulating neutrophils. First, these cells were able to respond
positively to T0901317 by up-regulating the mRNA levels of
LXRa target genes by several-fold together with its transcriptional
transactivation activity. Second, we describe for the first time that
LXRa mRNA transcription induced by its ligand is inhibited by
15dPGJ2 in a fashion similar to other model pro-inflammatory
molecules, such as IL-8, TNFa and IL-1, which inhibit LXR
transcription in human neutrophils, as similar manner as its do on
Hep3B human hepatoma cells [68]. With Regard to potential
mechanisms whereby 15dPGJ2 acts negatively on LXRa target
genes mRNA expression, present data suggest that its inhibitory
effect is exerted in a PPARc-independent manner, because, other
PPARc ligands do not have any effect on LXRa expression. These
data are in agreement with the fact that anti-atherogenic effect of
PPARc ligands are exerted in a LXR-independent manner in
macrophage foam-cell formation [69]. Furthermore, our data also
suggest that 15dPGJ2 inhibitory effect is performed in a ROS-
dependent manner. Several lines of research illustrate the
possibility that 15dPGJ2 effect could be exerted in a PPARc-
independent and ROS-dependent manner [70,71]. We have
found that such 15dPGJ2 negative effect was reversed by reducing
agents and mimicked by pro-oxidant molecules, this reflecting a
previously undescribed relationship between ROS production and
modulation of LXR expression. This observation could be very
important in the context of pathologies associated involving an
inflammatory process, since the relationship between LXR
activation and atherogenesis counteraction associated with reverse
cholesterol transport stimulation by LXRs is well known [56,72].
In addition, it is also noticeable the relationship between ROS
production and atherosclerotic vascular impairment [58,59,73].
Therefore, we can postulate that ROS production by neutrophils
occurring in different inflammatory processes might interfere with
other LXR-regulated events, such as atherosclerosis enhancement
or even its anti-inflammatory effect. This is evidenced by the fact
that inhibition of LXRa, by increased pro-oxidant condition,
reversed the LXRa anti-inflammatory effects on IL8 release and
ROS production induced by 15dPGJ2. In fact, this idea has
already been raised by other researchers concluding that ROS
may promote coronary artery disease by counteracting the
established anti-atherogenic effects of HDL and ABCA1 pathways
on the human artery wall [74]. Our data are also consistent with
recent reports that ROS mediate the IL-1b-induced down-
regulation of ABCA1 mRNA and protein in human macrophages
(THP-1 and A549 cell lines) [75], and that epigallocatechin-3-
gallate, which elevates ROS in the 3T3L1 adipocyte cell line, also
decreases LXRa expression [76]. However, the latter study did not
address whether this inhibitory effect was or not ROS-dependent.
15dPGJ2 did not negatively modulate only LXRa expression,
but also hindered mRNA transcription of its target genes ABCA1,
ABCG1 and SREBP1c in T0901317-stimulated human neutro-
phils (although its effect on SREBP1c was not statistically
significant). These data are in agreement with the well known
fact that these three genes are LXR-regulated in rodent and
human cells, via functional LXR response elements found in their
promoters [7,56,77]. Therefore, it seems that 15dPGJ2, by
negatively modulating LXRa transcription factor activity, disables
the expression of LXR target genes. Additionally, LXR activity
appears to be regulated by post-translational modification, such as
phosphorylation exerted by MAPKs, as it is the case for other
nuclear receptors [51,78,79]. This led us to analyze the potential
implication of these protein kinases in the modulation of LXR
mRNA expression by testing the effect on this process of a set of
MAPK inhibitors targeting p38, ERK1/2 and JNK1/2. Among
these, neither SB203580 nor SP600125 had any effect on LXRa
transcription, which reflected the lack of implication of p38
MAPK and JNK1/2. However, we found that treatment of
neutrophils with PD098059, an inhibitor of ERK1/2 upstream
activator, MEK1/2, resulted in a dramatic enhancement of
mRNA synthesis of LXRa and other target genes induced by
T0901317. Even, PD098059 alone was able to slightly increase
transcription of these genes. In contrast, it has been very recently
described in macrophages that ERK1/2 inhibitors do not affect
LXRa/b protein expression, although they increase free choles-
terol efflux and ABCA1 expression in this cell type [80].
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Additionally, we present evidence that PD098059 potently cancels
15dPGJ2 inhibition of mRNA synthesis of LXRa and other target
genes. These data strongly suggested that ERK1/2 activation is
involved in the down-regulation of T0901317-induced transcrip-
tion LXRa of target genes exerted by 15dPGJ2 in human
neutrophils. In fact, we have detected that 15dPGJ2 elicited
ERK1/2 phosphorylation in a PPARc-independent manner, in
similarity to reports in other cells [81,82], and that this effect was
dependent on ROS production. This conclusion was further
supported by the fact that other down-regulator of LXRa target
genes used in this work, such as other prostaglandins, promoted as
well ERK1/2 phosphorylation in human neutrophils. Therefore,
in these cells LXR activity appears to be regulated, in addition to
at the transcriptional level, through post-translational modification
elicited by T0901317 and 15dPGJ2. In this context, we have found
that the LXRa protein undergoes serine phosphorylation
promoted by its ligand, T0901317. This result is in line with the
previous observation that selective regulation of LXRa target gene
expression, rather than expression of the LXRa gene itself, is
achieved in macrophages by phosphorylation of the LXRa at Ser-
198 [47], a residue located within a consensus target for the
MAPK family [46]. Our data in human neutrophils indicate that
15dPGJ2 treatment induces an increased phosphorylation at
undetermined serine residue(s) of the LXRa.
In summary, our results support the notion that pro-inflamma-
tory stimuli such as 15dPGJ2, together with associated ROS
production, down-regulate the LXRa and at least some of its other
target genes at the mRNA expression level in human neutrophils
by promoting an alteration of the LXRa phosphorylation status in
an ERK1/2-dependent manner. Whichever the action exerted by
oxysterols (i.e., pro- versus anti-inflammatory), experiments in this
work clearly indicate that LXR transcription becomes depressed
under oxidative conditions. This is highly suggestive that
neutrophils, alike other phagocytic cells, could be associated with
the high oxidative state found in atherogenic injury conditions
[58,59,73]. This pro-oxidant environment would promote the
formation of the atherosclerotic plaque through the direct negative
modulation of LXR activity. Present studies we believe open up
the new paradigm of a cross-talk between nutritional transcription
factors modulating fatty acid metabolism and oxidative stress in
human circulating blood cells.
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